IGFBP2 Monoclonal Antibody (1F6F6), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA515400-Each-of-1 | In Stock | ₹ 55,625.00 |
PIMA515400 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 55,625.00
GST (18%): ₹ 10,012.50
Total Price: ₹ 65,637.50
Antigen
IGFBP2
Classification
Monoclonal
Concentration
Conc. Not Determined
Formulation
ascites with 0.03% sodium azide
Gene Accession No.
P18065
Gene Symbols
IGFBP2
Immunogen
Purified recombinant fragment of protein IGFBP2 (aa180-328) expressed in E. Coli.
Regulatory Status
RUO
Gene ID (Entrez)
3485
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
ELISA, Immunohistochemistry, Western Blot
Clone
1F6F6
Conjugate
Unconjugated
Gene
IGFBP2
Gene Alias
AI255832; BP2; BRL-BP; IBP2; IBP-2; IGF binding protein 2; IGF-binding protein 2; IGFBP; IGFBP2; IGFBP-2; IGF-BP53; ILGFBPA; Insulin like growth factor binding protein; insulin like growth factor binding protein 2; insulin-like growth factor binding protein 2; insulin-like growth factor binding protein 2, 36kDa; insulin-like growth factor-binding protein 2; mIGFBP-2; OTTHUMP00000207753
Host Species
Mouse
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG1
Related Products
Description
- MA5-15400 targets IGFBP2 in indirect ELISA, IHC and WB applications and shows reactivity with Human samples
- The MA5-15400 immunogen is purified recombinant fragment of protein IGFBP2 (aa180-328) expressed in E
- Coli
- <br>
- IGFBP2 (insulin-like growth factor binding protein 2) is a member of the ISGBP family which bind various IGFs
- IGFBP2 is overexpressed in a wide spectrum of cancers, including glioma, prostate cancer, synovial sarcoma, neuroblastoma, colon cancer, adrenocortical cancer, lung cancer, Wilms' tumor, and hepatoblastoma
- The overexpression of IGFBP2 also correlates with the aggressiveness of some tumors
- IGFBP2 activates the expression of matrix metalloprotease 2, which contributes to cell invasiveness.